作者
Yuchen Jiao,Timothy M. Pawlik,Robert A. Anders,Florin M. Selaru,Mirte Mayke Streppel,Donald J. Lucas,Noushin Niknafs,Violeta Beleva Guthrie,Anirban Maitra,Pedram Argani,G. Johan A. Offerhaus,Juan Carlos Roa,Lewis R. Roberts,Gregory J. Gores,Irinel Popescu,Sorin Alexandrescu,Simona Dima,Matteo Fassan,Michele Simbolo,Andrea Mafficini,Paola Capelli,Rita T. Lawlor,Andrea Ruzzenente,Alfredo Guglielmi,Giampaolo Tortora,Filippo de Braud,Aldo Scarpa,William R. Jarnagin,David S. Klimstra,Rachel Karchin,Victor E. Velculescu,Ralph H. Hruban,Bert Vogelstein,Kenneth W. Kinzler,Nickolas Papadopoulos,Laura D. Wood
摘要
Through exomic sequencing of 32 intrahepatic cholangiocarcinomas, we discovered frequent inactivating mutations in multiple chromatin-remodeling genes (including BAP1, ARID1A and PBRM1), and mutation in one of these genes occurred in almost half of the carcinomas sequenced. We also identified frequent mutations at previously reported hotspots in the IDH1 and IDH2 genes encoding metabolic enzymes in intrahepatic cholangiocarcinomas. In contrast, TP53 was the most frequently altered gene in a series of nine gallbladder carcinomas. These discoveries highlight the key role of dysregulated chromatin remodeling in intrahepatic cholangiocarcinomas.